<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="54260">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02399761</url>
  </required_header>
  <id_info>
    <org_study_id>201205084RIC</org_study_id>
    <nct_id>NCT02399761</nct_id>
  </id_info>
  <brief_title>Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency</brief_title>
  <official_title>Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parents of newborns will be invited to test if their newborns are affected with Aromatic
      L-amino Acid Decarboxylase (AADC) deficiency.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parents of newborns will be invited to test if their newborns are affected with Aromatic
      L-amino Acid Decarboxylase (AADC) deficiency. The routine newborn screening dried blood
      spots sample will be used to test if 3-O-methyldopa (3-OMD) concentration elevates. If
      positive of screening test, further confirmation tests including physical examination and
      for mutation. Genetic counseling and treatment option will be provided, too.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of newborns with AADC deficiency</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200000</enrollment>
  <condition>Aromatic L-amino Acid Decarboxylase Deficiency</condition>
  <eligibility>
    <study_pop>
      <textblock>
        newborns whose parents agree to be tested
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Babies born in Taiwan receive regular new born screening suggested by Ministry of
             Heath and Welfare.

          -  Parents or Legal Guardian sign in the informed consent form.

        Exclusion Criteria:

          -  Parents or Legal Guardian do not agree to sign in the informed consent form.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yin-Hsiu Chien</last_name>
    <phone>886223123456</phone>
    <phone_ext>71937</phone_ext>
    <email>chienyh@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <lastchanged_date>April 11, 2016</lastchanged_date>
  <firstreceived_date>March 21, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Taiwan University Hospital</investigator_affiliation>
    <investigator_full_name>National Taiwan University Hospital</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>AADC deficiency, newborn screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amino Acid Metabolism, Inborn Errors</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dopa Decarboxylase</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
